Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in Neurology

Retrieve available abstracts of 296 articles:
HTML format



Single Articles


    June 2022
  1. FREEDMAN MS, Pozzilli C, Havrdova EK, Lemle A, et al
    Long-term Treatment With Ponesimod in Relapsing-Remitting Multiple Sclerosis: Results from Randomized Phase 2b Core and Extension Studies.
    Neurology. 2022 Jun 6. pii: WNL.0000000000200606.
    PubMed     Abstract available


    May 2022
  2. SOTIRCHOS ES, Vasileiou ES, Filippatou AG, Fitzgerald KC, et al
    Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
    Neurology. 2022 May 26. pii: WNL.0000000000200778.
    PubMed     Abstract available


  3. GRAVES J
    Identifying Multiple Sclerosis Activity: Do the Eyes Have It?
    Neurology. 2022 May 26. pii: WNL.0000000000200903.
    PubMed    


  4. YANG JH, Graves JS
    Cancer Screening in Patients With Multiple Sclerosis: Are We Doing Enough?
    Neurology. 2022;98:737-738.
    PubMed    


  5. LANGER-GOULD AM, Gonzales EG, Smith JB, Li BH, et al
    Racial and Ethnic Disparities in Multiple Sclerosis Prevalence.
    Neurology. 2022;98:e1818-e1827.
    PubMed     Abstract available


  6. GROOME PA, Webber C, Maxwell CJ, McClintock C, et al
    Multiple Sclerosis and the Cancer Diagnosis: Diagnostic Route, Cancer Stage, and the Diagnostic Interval in Breast and Colorectal Cancer.
    Neurology. 2022;98:e1798-e1809.
    PubMed     Abstract available


    April 2022
  7. WU Q, Zhao CW, Dai S
    Teaching Video NeuroImage: Generalized Reflex Myoclonus in Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome.
    Neurology. 2022 Apr 29. pii: WNL.0000000000200733.
    PubMed    


  8. YANG JH, Graves JS
    Cancer Screening in Patients With Multiple Sclerosis: Are We Doing Enough?
    Neurology. 2022 Apr 28. pii: WNL.0000000000200366.
    PubMed    


  9. HAMILTON R, Ciccarelli O
    Multiple Sclerosis Incidence in Black Patients: It's Time to Do Away With a Racial Medical Myth.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200309.
    PubMed    


  10. LANGER-GOULD AM, Gonzales EG, Smith JB, Li BH, et al
    Racial and Ethnic Disparities in Multiple Sclerosis Prevalence.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200151.
    PubMed     Abstract available


  11. GROOME PA, Webber C, Maxwell CJ, McClintock C, et al
    Multiple Sclerosis and the Cancer Diagnosis: Diagnostic Route, Cancer Stage, and the Diagnostic Interval in Breast and Colorectal Cancer.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200163.
    PubMed     Abstract available


  12. ROTSTEIN D, Solomon JM, Sormani MP, Montalban X, et al
    Association of No Evidence of Disease Activity With No Long-term Disability Progression in Multiple Sclerosis: A Systematic Review and Meta-analysis.
    Neurology. 2022 Apr 26. pii: WNL.0000000000200549.
    PubMed     Abstract available


  13. OKAI AF, Howard AM, Williams MJ, Brink JD, et al
    Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.
    Neurology. 2022 Apr 25. pii: WNL.0000000000200791.
    PubMed     Abstract available


  14. PORTACCIO E, Bellinvia A, Razzolini L, Pasto L, et al
    Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset.
    Neurology. 2022;98:e1626-e1636.
    PubMed     Abstract available


  15. SWART G, Balgobind S, Chan C, Fulham M, et al
    Spinal Cord Presentation of Biopsy-Proven PET-Positive Giant Cell Arteritis.
    Neurology. 2022 Apr 15. pii: WNL.0000000000200749.
    PubMed     Abstract available


  16. BEBO B, Cintina I, LaRocca N, Ritter L, et al
    Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200150.
    PubMed     Abstract available


  17. OSTKAMP P, Schwab N
    Effects of Latitude and Sunlight on Multiple Sclerosis Severity: Two Peas in a Pod?
    Neurology. 2022 Apr 11. pii: WNL.0000000000200105.
    PubMed    


  18. VITKOVA M, Diouf I, Malpas C, Horakova D, et al
    Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study.
    Neurology. 2022 Apr 11. pii: WNL.0000000000200545.
    PubMed     Abstract available


  19. GUASP M, Martin-Aguilar L, Sabater L, Bioque M, et al
    Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Neurology. 2022;98:e1489-e1498.
    PubMed     Abstract available


  20. LEPPERT D, Kropshofer H, Haring DAA, Dahlke F, et al
    Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
    Neurology. 2022 Apr 4. pii: WNL.0000000000200258.
    PubMed     Abstract available


    March 2022
  21. GALLAY L, Fermon C, Lessard L, Weiss-Gayet M, et al
    Involvement of Type-I Interferon Signaling in Muscle Stem Cell Proliferation During Dermatomyositis.
    Neurology. 2022 Mar 29. pii: WNL.0000000000200271.
    PubMed     Abstract available


  22. PINAL-FERNANDEZ I, Greenberg SA
    Type I Interferons in Dermatomyositis Myoblasts: Toxic Effect and a Potential Autocrine Loop.
    Neurology. 2022 Mar 29. pii: WNL.0000000000200679.
    PubMed    


  23. BOURDETTE D, Sormani MP
    Thinking Anew: Accelerating Clinical Trials of New Therapies for Progressive Multiple Sclerosis.
    Neurology. 2022 Mar 23. pii: WNL.0000000000200597.
    PubMed    


  24. LI V, Leurent B, Barkhof F, Braisher M, et al
    Designing Multi-arm Multistage Adaptive Trials for Neuroprotection in Progressive Multiple Sclerosis.
    Neurology. 2022 Mar 23. pii: WNL.0000000000200604.
    PubMed     Abstract available


  25. MOLIMARD A, Gitiaux C, Barnerias C, Audic F, et al
    Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French Experience.
    Neurology. 2022 Mar 21. pii: WNL.0000000000200288.
    PubMed     Abstract available


  26. BRIDEL C, Killestein J, Teunissen C
    Author Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022;98:471.
    PubMed    


  27. KROPSHOFER H, Haring DA, Kappos L, Leppert D, et al
    Reader Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022;98:470-471.
    PubMed    


  28. LEWIS A, Galetta S
    Editors' Note: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022;98:470.
    PubMed    


  29. HUMMERT MW, Schoppe LM, Bellmann-Strobl J, Siebert N, et al
    Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCE(NMO) Study.
    Neurology. 2022;98:e1184-e1196.
    PubMed     Abstract available


  30. SIMMONS SB, Ontaneda D
    Slowly Expanding Lesions: A New Target for Progressive Multiple Sclerosis Trials?
    Neurology. 2022 Mar 11. pii: WNL.0000000000200230.
    PubMed    


  31. AZZOLINI F, Farina A, Gastaldi M, Barilaro A, et al
    Leptomeningeal Gadolinium Enhancement in Autoimmune GFAP-Astrocytopathy.
    Neurology. 2022 Mar 11. pii: WNL.0000000000200291.
    PubMed    


  32. CALVI A, Carrasco FP, Tur C, Chard DT, et al
    Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis.
    Neurology. 2022 Mar 11. pii: WNL.0000000000200144.
    PubMed     Abstract available


  33. ZENG YH, Zhao M, Guo XX, Wang N, et al
    Cutaneous Lesions as a Clue to the Etiology of Extensive Intracranial Calcifications: Aicardi-Goutieres Syndrome.
    Neurology. 2022;98:417-418.
    PubMed    


  34. LEVISON LS, Thomsen RW, Sindrup SH, Andersen H, et al
    Association Between Incident Cancer and Guillain-Barre Syndrome Development: A Nationwide Case-Control Study.
    Neurology. 2022 Mar 2. pii: WNL.0000000000200015.
    PubMed     Abstract available


  35. HAMILTON RH, Ciccarelli O
    Non-White Participants Matter in White Matter Disease Studies: The Importance of Diversity in Multiple Sclerosis Clinical Trials.
    Neurology. 2022;98:345-346.
    PubMed    


    February 2022
  36. MARZOUGHI S, Marulanda L, Ngo D, Chen T, et al
    Pearls & Oy-sters: Delayed Diagnosis of Acute Motor Axonal Neuropathy With Cardiac Arrest.
    Neurology. 2022;98:336-339.
    PubMed    


  37. LIE IA, Weeda MM, Mattiesing RM, Mol MAE, et al
    Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review.
    Neurology. 2022 Feb 16. pii: WNL.0000000000200006.
    PubMed     Abstract available


  38. MCELWEE DECKER B, Thibault D, Davis KA, Willis AW, et al
    Population-Based Study of Nonelective Postpartum Readmissions in Women With Stroke, Migraine, Multiple Sclerosis, and Myasthenia Gravis.
    Neurology. 2022 Feb 15. pii: WNL.0000000000200007.
    PubMed     Abstract available


  39. HACOHEN Y, Ciccarelli O
    New Evidence for EBV Infection as a Cause of Multiple Sclerosis.
    Neurology. 2022 Feb 10. pii: WNL.0000000000200243.
    PubMed    


  40. MAMMEN AL
    Inclusion Body Myositis: An Autoimmune or Myodegenerative Disease?
    Neurology. 2022 Feb 7. pii: WNL.0000000000200188.
    PubMed    


  41. TORTORELLA C, Aiello A, Gasperini C, Agrati C, et al
    Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.
    Neurology. 2022;98:e541-e554.
    PubMed     Abstract available


    January 2022
  42. ONUORAH HM, Charron O, Meltzer E, Montague A, et al
    Enrollment of Non-White Participants and Reporting of Race and Ethnicity in Phase III Trials of Multiple Sclerosis DMTs: A Systematic Review.
    Neurology. 2022 Jan 19. pii: WNL.0000000000013230.
    PubMed     Abstract available


  43. CUTTER GR, Koch MW
    Multiple Sclerosis Diagnostic Criteria: Moving Ahead or Walking in Place?
    Neurology. 2022;98:12-13.
    PubMed    


  44. FILIPPI M, Preziosa P, Meani A, Dalla Costa G, et al
    Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome: A MAGNIMS Study.
    Neurology. 2022;98:e1-e14.
    PubMed     Abstract available


    December 2021
  45. DOETS AY, Lingsma HF, Walgaard C, Islam B, et al
    Predicting Outcome in Guillain-Barre Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
    Neurology. 2021 Dec 22. pii: WNL.0000000000013139.
    PubMed     Abstract available


  46. MIRZA AI, Zhu F, Knox N, Forbes JD, et al
    Metagenomic Analysis of the Pediatric-Onset Multiple Sclerosis Gut Microbiome.
    Neurology. 2021 Dec 22. pii: WNL.0000000000013245.
    PubMed     Abstract available


  47. COSTA AF, Rodriguez A, Martinez P, Blanco DCM, et al
    Teaching Video NeuroImage: Uncommon Neuro-ophthalmic Finding in a Patient With Miller Fisher Syndrome and Past SARS-CoV-2 Infection.
    Neurology. 2021;97:e2431-e2432.
    PubMed    


  48. SHELLY S, Klein CJ, Dyck PJB, Paul P, et al
    Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
    Neurology. 2021;97:e2392-e2403.
    PubMed     Abstract available


  49. SEBASTIAN P, Cherbuin N, Barcellos LF, Roalstad S, et al
    Association Between Time Spent Outdoors and Risk of Multiple Sclerosis.
    Neurology. 2021 Dec 8. pii: WNL.0000000000013045.
    PubMed     Abstract available


  50. GRAVES JS, Killestein J
    Reading the "T" Leaves of COVID-19 Vaccine Responses in Multiple Sclerosis.
    Neurology. 2021 Dec 8. pii: WNL.0000000000013166.
    PubMed    


  51. TANBOON J, Inoue M, Saito Y, Tachimori H, et al
    Dermatomyositis: Muscle Pathology According to Antibody Subtypes.
    Neurology. 2021 Dec 6. pii: WNL.0000000000013176.
    PubMed     Abstract available


  52. NOWAK RJ, Coffey CS, Goldstein JM, Dimachkie MM, et al
    Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.
    Neurology. 2021 Dec 2. pii: WNL.0000000000013121.
    PubMed     Abstract available


    November 2021
  53. NEUPERT DG, Rathke KM, Mikati MA
    Teaching Video NeuroImage: Hereditary Hyperekplexia Mimicking Tonic Seizures in an Infant.
    Neurology. 2021;97:e2248-e2249.
    PubMed     Abstract available


  54. TENCER J, Yum SW
    Teaching NeuroImage: Basal Ganglia T1 Hyperintensity and SWI Signal Diabetic Striatopathy in an 18-Year-Old Man With Type 1 Diabetes Mellitus.
    Neurology. 2021;97:e2148-e2149.
    PubMed    


  55. DUMONCEAU AG, Ameli R, Rogemond V, Ruiz A, et al
    Glial Fibrillary Acidic Protein Autoimmunity: A French Cohort Study.
    Neurology. 2021 Nov 19. pii: WNL.0000000000013087.
    PubMed     Abstract available


    October 2021

  56. Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study.
    Neurology. 2021 Oct 29. pii: WNL.0000000000013021.
    PubMed    


  57. AMATO A
    Author Response: Guillain-Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.
    Neurology. 2021;97:841-842.
    PubMed    


  58. WILLER J
    Reader Response: Guillain-Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial.
    Neurology. 2021;97:841.
    PubMed    


  59. TINTORE M, Cobo-Calvo A, Carbonell P, Arrambide G, et al
    Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated Syndrome.
    Neurology. 2021;97:e1641-e1652.
    PubMed     Abstract available


  60. AA HOGLUND RA, Meyer HE, Stigum H, Torkildsen O, et al
    Association of Body Mass Index in Adolescence and Young Adulthood and Long-term Risk of Multiple Sclerosis: A Population-Based Study.
    Neurology. 2021 Oct 25. pii: WNL.0000000000012957.
    PubMed     Abstract available


  61. KALINCIK T, Tremlett H, Ascherio A
    High BMI In Youths as a Modifiable Risk Factor for Multiple Sclerosis: Weighing Up the Evidence.
    Neurology. 2021 Oct 25. pii: WNL.0000000000012966.
    PubMed    


  62. AGHAJAN Y, Mitchell RN, Bhattacharyya S, Hsu TY, et al
    Teaching NeuroImage: Bilateral Middle Cerebellar Peduncle Stroke in Giant Cell Arteritis.
    Neurology. 2021 Oct 19. pii: WNL.0000000000012953.
    PubMed    


  63. JANDRIC D, Lipp I, Paling D, Rog D, et al
    Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis.
    Neurology. 2021 Oct 14. pii: WNL.0000000000012834.
    PubMed     Abstract available


  64. SANCHEZ CV, Theel E, Binnicker M, Toledano M, et al
    Autoimmune Encephalitis Post-SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.
    Neurology. 2021 Oct 11. pii: WNL.0000000000012931.
    PubMed     Abstract available


  65. SIMPSON-YAP S, De Brouwer E, Kalincik T, Rijke N, et al
    Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
    Neurology. 2021 Oct 5. pii: WNL.0000000000012753.
    PubMed     Abstract available


  66. KILLESTEIN J, Schoonheim MM, Voskuhl RR
    B-Cell Depletion and COVID-19 Severity in Multiple Sclerosis: Remaining Challenges.
    Neurology. 2021 Oct 5. pii: WNL.0000000000012754.
    PubMed    


  67. BONACCHI R, Meani A, Pagani E, Marchesi O, et al
    Association of Age at Onset With Gray Matter Volume and White Matter Microstructural Abnormalities in People With Multiple Sclerosis.
    Neurology. 2021 Oct 4. pii: WNL.0000000000012869.
    PubMed     Abstract available


  68. HACOHEN Y, Eshaghi A
    Multiple Sclerosis in Children and Adults: Does Age Matter?
    Neurology. 2021 Oct 4. pii: WNL.0000000000012866.
    PubMed    


  69. VRENKEN H, Jenkinson M, Pham D, Guttmann CRG, et al
    Opportunities for Understanding MS Mechanisms and Progression With MRI Using Large-Scale Data Sharing and Artificial Intelligence.
    Neurology. 2021 Oct 4. pii: WNL.0000000000012884.
    PubMed     Abstract available


    September 2021
  70. ZHAO-FLEMING HH, Valencia Sanchez C, Sechi E, Inbarasu J, et al
    CNS Demyelinating Attacks Requiring Ventilatory Support With Myelin Oligodendrocyte Glycoprotein or Aquaporin-4 Antibodies.
    Neurology. 2021;97:e1351-e1358.
    PubMed     Abstract available


  71. MERLO D, Stankovich J, Bai C, Kalincik T, et al
    Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Sep 23. pii: WNL.0000000000012850.
    PubMed     Abstract available


  72. MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
    Colorectal Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.
    Neurology. 2021 Sep 15. pii: WNL.0000000000012634.
    PubMed     Abstract available


  73. TOBIN O
    Early Diagnosis and Treatment is Associated With Improved Outcomes in Patients With Multiple Sclerosis.
    Neurology. 2021 Sep 14. pii: WNL.0000000000012738.
    PubMed    


  74. CAMELO-FILHO AE, Estephan EP, Heise CO, Zanoteli E, et al
    Teaching Video NeuroImage: Reflex Facilitation in Lambert-Eaton Myasthenic Syndrome.
    Neurology. 2021;97:e1168-e1169.
    PubMed    


  75. MILLER JW
    Inflammation As A Target For Epilepsy Therapy: The Case of Natalizumab.
    Neurology. 2021 Sep 14. pii: WNL.0000000000012768.
    PubMed    


  76. GOLDSCHMIDT C, Fox RJ
    Relationship Between Serum Neurofilament Light and Multiple Sclerosis Disability Progression: Clear as Mud.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012755.
    PubMed    


  77. TOBIN WO, Kalinowska-Lyszczarz A, Weigand SD, Guo Y, et al
    Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012782.
    PubMed     Abstract available


  78. BRIDEL C, Leurs CE, van Lierop ZY, van Kempen ZL, et al
    Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012752.
    PubMed     Abstract available


  79. RADCLIFFE C, Potnis K, Peng TJ, DeCroce-Movson E, et al
    Teaching NeuroImage: Papilledema and Pachymeningitis: An Atypical Presentation of Granulomatosis With Polyangiitis.
    Neurology. 2021;97:e1060-e1061.
    PubMed    


  80. YEH EA, Bourdette D, Wiendl H
    Longer-Term Safety of B-Cell Therapy With Ocrelizumab in Multiple Sclerosis.
    Neurology. 2021 Sep 2. pii: WNL.0000000000012716.
    PubMed    


  81. HAUSER SL, Kappos L, Montalban X, Craveiro L, et al
    Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.
    Neurology. 2021 Sep 2. pii: WNL.0000000000012700.
    PubMed     Abstract available


  82. PALLADINO R, Chataway J, Majeed A, Marrie RA, et al
    Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality: A Population-Based Matched Cohort Study.
    Neurology. 2021 Sep 1. pii: WNL.0000000000012610.
    PubMed     Abstract available


  83. SALTER A
    Assessment of Biological Interactions Between MS Status and Depression for Mortality.
    Neurology. 2021 Sep 1. pii: WNL.0000000000012615.
    PubMed    


    August 2021
  84. RICE J, Xiang XM
    Comparing the Effectiveness of Therapies in People With Secondary Progressive Multiple Sclerosis.
    Neurology. 2021;97:e972-e974.
    PubMed    


  85. DOBSON R, Salter A
    Differing Impact of Disease-Modifying Therapy on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately?
    Neurology. 2021;97:407-408.
    PubMed    


  86. KOCH MW, Mostert JP, Wolinsky JS, Lublin FD, et al
    Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2021 Aug 25. pii: WNL.0000000000012690.
    PubMed     Abstract available


  87. PETERSSON M, Feresiadou A, Jons D, Ilinca A, et al
    Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012604.
    PubMed     Abstract available


  88. KOCH MW, Mostert J, Zhang Y, Wolinsky JS, et al
    Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012603.
    PubMed     Abstract available


  89. FREY J, Kramer J, Castellani R, Sriwastava S, et al
    Clinical Reasoning: A 47-Year-Old With Headache, Vertigo, and Double Vision.
    Neurology. 2021;97:e535-e539.
    PubMed    


  90. STRUPP M, Frenzel C, Goldschagg N, Halmagyi GM, et al
    Teaching Video NeuroImage: One Bedside Test, 2 Clinical Signs: One Vestibular, the Other Ocular Motor.
    Neurology. 2021;97:e541-e542.
    PubMed    


    July 2021
  91. KARCESKI S
    Myasthenia Gravis: Which Type of Surgery Is Best?
    Neurology. 2021;97:e433-e435.
    PubMed    


  92. CHEN T
    Clinical Reasoning: A 68-Year-Old Man With Proximal Weakness and Seizures.
    Neurology. 2021;97:e423-e428.
    PubMed    


  93. SECHI E, Krecke KN, Messina SA, Buciuc M, et al
    Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders.
    Neurology. 2021 Jul 14. pii: WNL.0000000000012467.
    PubMed     Abstract available


  94. RASMINSKY M
    GCA Squared.
    Neurology. 2021;97:90-91.
    PubMed    


  95. NICHOLAS RS, Rhone EE, Mariottini A, Silber E, et al
    Autologous Haematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: a Real-world Case Series.
    Neurology. 2021 Jul 12. pii: WNL.0000000000012449.
    PubMed     Abstract available


  96. LISAK RP
    [Editorial] At the Junction Where It Happens: Antibodies to LRP4 and Agrin Are Pathogenic in Myasthenia Gravis [re: M/S #2020/169756].
    Neurology. 2021 Jul 7. pii: WNL.0000000000012471.
    PubMed    


  97. YU Z, Zhang M, Jing H, Chen P, et al
    Characterization of LRP4/Agrin Antibodies From a Patient with Myasthenia Gravis.
    Neurology. 2021 Jul 7. pii: WNL.0000000000012463.
    PubMed     Abstract available


  98. HACOHEN Y, Kerr W, Waters P
    Intrathecal Production of MOG-IgG: Highlighting the Need for CSF Testing in Clinical Practice.
    Neurology. 2021;97:12-13.
    PubMed    


  99. AKAISHI T, Takahashi T, Misu T, Kaneko K, et al
    Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder.
    Neurology. 2021;97:e1-e12.
    PubMed     Abstract available


  100. GUASP M, Gine-Serven E, Maudes E, Rosa-Justicia M, et al
    Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis.
    Neurology. 2021;97:e61-e75.
    PubMed     Abstract available


    June 2021
  101. GRAY-RONCAL K, Fitzgerald K, Ryerson LZ, Charvet L, et al
    Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis.
    Neurology. 2021 Jun 30. pii: WNL.0000000000012362.
    PubMed     Abstract available


  102. ROOS I, Leray E, Casey R, Horakova D, et al
    Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis.
    Neurology. 2021 Jun 30. pii: WNL.0000000000012354.
    PubMed     Abstract available


  103. MYERS KA
    Author Response: Teaching Video NeuroImages: Pathologic Yawning: A Sign of Brainstem Involvement in Acute Disseminated Encephalomyelitis?
    Neurology. 2021;96:1105.
    PubMed    


  104. FUJIMORI J, Nakashima I
    Reader Response: Teaching Video NeuroImages: Pathologic Yawning: A Sign of Brainstem Involvement in Acute Disseminated Encephalomyelitis?
    Neurology. 2021;96:1104-1105.
    PubMed    


  105. VILLACIEROS-ALVAREZ J, Ordas CM, Torres-Gaona G, Diez-Barrio A, et al
    Teaching Video NeuroImages: Anti-IgLON5 Disease: A Long-Course Presentation With a Response to Immunotherapy.
    Neurology. 2021;96:e2901-e2902.
    PubMed    


  106. HUISKAMP M, Eijlers AJC, Broeders TAA, Pasteuning J, et al
    Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis.
    Neurology. 2021 Jun 7. pii: WNL.0000000000012341.
    PubMed     Abstract available


  107. PREZIOSA P, Schoonheim MM
    Ongoing Axonal Injury in Chronic Active Lesions in Multiple Sclerosis: In-Vivo Quantification Using Serum Neurofilament.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012331.
    PubMed    


  108. CAMPBELL CREE BA, Arnold DL, Chataway J, Chitnis T, et al
    Secondary Progressive Multiple Sclerosis: New Insights.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012323.
    PubMed     Abstract available


  109. MAGGI P, Kuhle J, Schadelin S, van der Meer F, et al
    Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012326.
    PubMed     Abstract available


    May 2021
  110. SAN MARTIN AH, Cuadrado CA, Arbizu MG, Rabano-Suarez P, et al
    Autoimmune Septin-5 Disease Presenting as Spinocerebellar Ataxia and Nystagmus.
    Neurology. 2021 May 24. pii: WNL.0000000000012240.
    PubMed    


  111. ROLLOT F, Fauvernier M, Uhry Z, Vukusic S, et al
    Effects of Age and Disease Duration on Excess Mortality in Patients With Multiple Sclerosis From a French Nationwide Cohort.
    Neurology. 2021 May 19. pii: WNL.0000000000012224.
    PubMed     Abstract available


  112. MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
    Breast Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.
    Neurology. 2021 May 19. pii: WNL.0000000000012127.
    PubMed     Abstract available


  113. JOLLIFFE EA, Guo Y, Hardy TA, Morris PP, et al
    Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis.
    Neurology. 2021 May 19. pii: WNL.0000000000012230.
    PubMed     Abstract available


  114. TOOSY AT, Kapur K, Nair KV
    Is OCT a Viable Tool to Monitor Disease-Modifying Treatments in RRMS Yet?
    Neurology. 2021;96:927-928.
    PubMed    


  115. DAY GS, Yarbrough MY, Kortvelyessy P, Pruss H, et al
    Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
    Neurology. 2021;96:e2546-e2557.
    PubMed     Abstract available


  116. TITULAER MJ, Day GS
    Autoimmune Encephalitis in First Episode Psychoses: All Smoke and No Fire?
    Neurology. 2021 May 12. pii: WNL.0000000000012195.
    PubMed    


  117. GIANNOCCARO MP, Liguori R
    Author Response: Comparison of Ice Pack Test and Single-Fiber EMG Diagnostic Accuracy in Patients Referred for Myasthenic Ptosis.
    Neurology. 2021;96:918-919.
    PubMed    


  118. SILVESTRI N
    Reader Response: Comparison of Ice Pack Test and Single-Fiber EMG Diagnostic Accuracy in Patients Referred for Myasthenic Ptosis.
    Neurology. 2021;96:918.
    PubMed    


  119. NERSESJAN V, McWilliam O, Krarup LH, Kondziella D, et al
    Autoimmune Encephalitis Related to Cancer Treatment With Immune Checkpoint Inhibitors: Systematic Review.
    Neurology. 2021 May 5. pii: WNL.0000000000012122.
    PubMed     Abstract available



  120. Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
    Neurology. 2021 May 4. pii: WNL.0000000000011825.
    PubMed    


  121. SOLIS-PAZMINO P, Baiu I, Lincango-Naranjo E, Trope W, et al
    Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis: A Meta-analysis.
    Neurology. 2021 May 4. pii: WNL.0000000000012153.
    PubMed     Abstract available


  122. FOX RJ, Kryscio RJ
    A New Way to Identify Promising Therapies for Progressive Multiple Sclerosis.
    Neurology. 2021;96:833-834.
    PubMed    


  123. KOCH MW, Sage K, Kaur S, Kim J, et al
    Repurposing Domperidone in Secondary Progressive Multiple Sclerosis: A Simon 2-Stage Phase 2 Futility Trial.
    Neurology. 2021;96:e2313-e2322.
    PubMed     Abstract available


  124. BAR-OR A, Herman A, Stokmaier D
    Author Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
    Neurology. 2021;96:870.
    PubMed    


  125. HAHN N
    Reader Response: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
    Neurology. 2021;96:870.
    PubMed    


  126. SIEGLER JE, Galetta S
    Editors' Note: Effect of Ocrelizumab on Vaccine Responses in Patients With Multiple Sclerosis: The VELOCE Study.
    Neurology. 2021;96:869.
    PubMed    


    April 2021
  127. DUBESSY AL, Tezenas du Montcel S, Viala F, Assouad R, et al
    Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis: A Polysomnographic Study.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012120.
    PubMed     Abstract available


  128. ZOUVELOU V, Daponte A
    Teaching Video NeuroImages: Resolution of Ptosis After Forceful Eye Closure: Bedside Diagnosis of Myasthenia Gravis.
    Neurology. 2021 Apr 30. pii: WNL.0000000000012100.
    PubMed    


  129. LEAVITT VM, Dobson R, Svennigsson A
    Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress.
    Neurology. 2021 Apr 28. pii: WNL.0000000000012101.
    PubMed    


  130. SHELLY S, Mills JR, Dubey D, McKeon A, et al
    Clinical Utility of Striational Antibodies in Paraneoplastic and Myasthenia Gravis Paraneoplastic Panels.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012050.
    PubMed     Abstract available


  131. SALAVISA M, Serrazina F, Pires P, Correia AS, et al
    Teaching Video NeuroImages: Infratentorial Multiple Sclerosis Relapse Presenting as Continuous Hemifacial Myokymia.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012052.
    PubMed    


  132. GASPERI C, Hapfelmeier A, Daltrozzo T, Schneider A, et al
    Systematic Assessment of Medical Diagnoses Preceding the First Diagnosis of Multiple Sclerosis.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012074.
    PubMed     Abstract available


  133. SOLOMON AJ, Ascherio A
    Early Diagnosis of Multiple Sclerosis: Further Evidence for Missed Opportunity.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012087.
    PubMed    



  134. Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis.
    Neurology. 2021 Apr 23. pii: WNL.0000000000012021.
    PubMed    


  135. EID K, Torkildsen OF, Aarseth J, Flemmen HO, et al
    Perinatal Depression and Anxiety in Women with Multiple Sclerosis: A Population-Based Cohort Study.
    Neurology. 2021 Apr 21. pii: WNL.0000000000012062.
    PubMed     Abstract available


  136. YEH WZ, Widyastuti PA, Van der Walt A, Stankovich J, et al
    Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.
    Neurology. 2021 Apr 20. pii: WNL.0000000000012084.
    PubMed     Abstract available


  137. SHELLY S, Shouman K, Paul P, Engelstad J, et al
    Expanding the Spectrum of Chronic Immune Sensory Polyradiculopathy: CISP-Plus.
    Neurology. 2021;96:e2078-e2089.
    PubMed     Abstract available


  138. NISHIDA H, Kohyama K, Kumada S, Takanashi JI, et al
    Evaluation of the Diagnostic Criteria for Anti-NMDA Receptor Encephalitis in Japanese Children.
    Neurology. 2021;96:e2070-e2077.
    PubMed     Abstract available


  139. COLLONGUES N, Alves Do Rego C, Bourre B, Biotti D, et al
    Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica Disorder.
    Neurology. 2021;96:e2006-e2015.
    PubMed     Abstract available


  140. LAMBE J, Risher H, Filippatou AG, Murphy OC, et al
    Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
    Neurology. 2021 Apr 7. pii: WNL.0000000000011933.
    PubMed     Abstract available


  141. BOURDETTE D, Killestein J
    Quelling Public Fears about Guillain-Barre Syndrome and COVID-19 Vaccination.
    Neurology. 2021 Apr 6. pii: WNL.0000000000011882.
    PubMed    


  142. MARQUEZ LOZA AM, Holroyd KB, Johnson SA, Pilgrim DM, et al
    Guillain- Barre Syndrome in the Placebo and Active Arms of a COVID-19 Vaccine Clinical Trial: Temporal Associations Do Not Imply Causality.
    Neurology. 2021 Apr 6. pii: WNL.0000000000011881.
    PubMed    


  143. ALLEN JA, Pasnoor M, Dimachkie MM, Ajroud-Driss S, et al
    Quantifying Treatment-Related Fluctuations in CIDP: Results of the GRIPPER Study.
    Neurology. 2021;96:e1876-e1886.
    PubMed     Abstract available


    March 2021
  144. POIRION E, Tonietto M, Lejeune FX, Ricigliano VAG, et al
    Structural and Clinical Correlates of a Periventricular Gradient of Neuroinflammation in Multiple Sclerosis.
    Neurology. 2021 Mar 18. pii: WNL.0000000000011700.
    PubMed     Abstract available


  145. GARDIN T, Longbrake EE
    Inducing or "Unmasking" Autoimmunity? The Role of Immune Checkpoint Therapy in Propagating Neurologic Immune-Related Adverse Events.
    Neurology. 2021 Mar 16. pii: WNL.0000000000011812.
    PubMed    


  146. LAMBE J, Fitzgerald KC, Murphy OC, Filippatou AG, et al
    Association of Spectral-Domain OCT With Long-term Disability Worsening in Multiple Sclerosis.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011788.
    PubMed     Abstract available


  147. VILLOSLADA P, Galetta SL, Toosy A
    Seeing the Finish Line: Can Baseline OCT Values Predict Long-Term Disability and Therapeutic Management in Multiple Sclerosis?
    Neurology. 2021 Mar 2. pii: WNL.0000000000011793.
    PubMed    


  148. BANSAL P, Paul BS, Singh G
    Multiple Sclerosis Relapse Presenting As Sensorineural Hearing Loss.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011796.
    PubMed    


    February 2021
  149. MUTHUSAMY K, Boyer S, Patterson M, Bierau J, et al
    Neuroimaging Findings in Inosine Triphosphate Pyrophosphohydrolase (ITPase) Deficiency.
    Neurology. 2021 Feb 16. pii: WNL.0000000000011719.
    PubMed    


  150. KALAITZIDIS G, Calabresi PA
    Is Cerebrospinal Fluid Responsible for Innate Immune Cell Activation and Neurotoxicity in Multiple Sclerosis?
    Neurology. 2021 Feb 15. pii: WNL.0000000000011694.
    PubMed    



  151. Evaluation of Multiple Sclerosis Disability Outcome Measures Using Pooled Clinical Trial Data.
    Neurology. 2021 Feb 12. pii: WNL.0000000000011677.
    PubMed    


  152. SOLE G, Mathis S, Friedman D, Salort-Campana E, et al
    Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011669.
    PubMed     Abstract available


  153. ZEPHIR H, Poupart J, Deschamps R, Audoin B, et al
    Author Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
    Neurology. 2021;96:295-296.
    PubMed    


  154. LEITE MI
    Reader Response: Evaluation of Efficacy and Tolerability of First-Line Therapies in NMOSD.
    Neurology. 2021;96:294-295.
    PubMed    


  155. DALAKAS MC
    Limited Benefits Halt Enrollment in Hematopoietic Stem Cell Transplantation Trial for Stiff-Person Syndrome: Should There Be More to Come?
    Neurology. 2021;96:239-240.
    PubMed    


  156. BURT RK, Balabanov R, Han X, Quigley K, et al
    Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial.
    Neurology. 2021;96:e817-e830.
    PubMed     Abstract available


  157. RIM J, Byler M, Soldatos A, Notarangelo L, et al
    Opinion and Special Articles: Cerebellar Ataxia and Liver Failure Complicating IPEX Syndrome.
    Neurology. 2021;96:e956-e959.
    PubMed    


  158. VALLAT JM, Duchesne M, Corcia P, Richard L, et al
    The Wide Spectrum of Pathophysiologic Mechanisms of Paraproteinemic Neuropathy.
    Neurology. 2021;96:214-225.
    PubMed     Abstract available


  159. NISHI R, Koike H, Ohyama K, Fukami Y, et al
    Association Between IL-5 Levels and the Clinicopathologic Features of Eosinophilic Granulomatosis With Polyangiitis.
    Neurology. 2021;96:226-229.
    PubMed    


    January 2021
  160. ALPING P, Burman J, Lycke J, Frisell T, et al
    Safety of Alemtuzumab and Autologous Hematopoietic Stem Cell Transplantation Compared to Non-induction Therapies for Multiple Sclerosis.
    Neurology. 2021 Jan 29. pii: WNL.0000000000011545.
    PubMed     Abstract available


  161. BROWNLEE WJ, Galetta S
    Optic Nerve in Multiple Sclerosis Diagnostic Criteria: An Aye to the Eyes?
    Neurology. 2021;96:139-140.
    PubMed    


  162. SORMANI MP, Tur C, Barkhof F
    Ibudilast: A Paradigm Shift for Progressive Multiple Sclerosis?
    Neurology. 2021;96:141-142.
    PubMed    


  163. SPAGNI G, Tricoli L, Modoni A, Monforte M, et al
    Clinical Reasoning: A 71-Year-Old Man Presenting With Acute Onset Dysarthria and Dysphagia.
    Neurology. 2021;96:180-184.
    PubMed    


  164. BOFFA G, Massacesi L, Inglese M, Mariottini A, et al
    Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
    Neurology. 2021 Jan 20. pii: WNL.0000000000011461.
    PubMed     Abstract available


  165. LEAVITT VM, Rocca M
    Siponimod for Cognition in Secondary Progressive Multiple Sclerosis: Thinking Through the Evidence.
    Neurology. 2021;96:91-92.
    PubMed    


  166. ROCCA MA, Valsasina P, Meani A, Gobbi C, et al
    Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis.
    Neurology. 2021 Jan 13. pii: WNL.0000000000011494.
    PubMed     Abstract available


  167. PAPP V, Magyari M, Aktas O, Berger T, et al
    Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review.
    Neurology. 2021;96:59-77.
    PubMed     Abstract available


  168. GREEN C, Morrison H, Smith P, Golestani F, et al
    Teaching Neuroimages: COVID-19-Associated Acute Disseminated Encephalomyelitis With Corpus Callosal Hemorrhage.
    Neurology. 2021;96:e307-e308.
    PubMed    


  169. BOVIS F, Kalincik T, Lublin F, Cutter G, et al
    Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a.
    Neurology. 2021;96:e214-e227.
    PubMed     Abstract available


  170. SHAH S, Klassen BT, Flanagan EP
    Paroxysmal Dysarthria-Ataxia in Multiple Sclerosis.
    Neurology. 2021 Jan 5. pii: WNL.0000000000011498.
    PubMed    


  171. KALINCIK T, Sormani MP, Tur C
    Has the Time Come to Revisit Our Standard Measures of Disability Progression in Multiple Sclerosis?
    Neurology. 2021;96:12-13.
    PubMed    


    December 2020
  172. KALINCIK T, Diouf I, Sharmin S, Malpas C, et al
    Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years.
    Neurology. 2020 Dec 28. pii: WNL.0000000000011242.
    PubMed     Abstract available



  173. The 2013 clinical course descriptors for multiple sclerosis: A clarification.
    Neurology. 2020 Dec 22. pii: WNL.0000000000011198.
    PubMed    


  174. BENEDICT RHB, Tomic D, Cree BA, Fox R, et al
    Siponimod and cognition in secondary progressive multiple sclerosis: EXPAND secondary analyses.
    Neurology. 2020 Dec 16. pii: WNL.0000000000011275.
    PubMed     Abstract available


  175. VIDAL-JORDANA A, Rovira A, Arrambide G, Otero-Romero S, et al
    Optic nerve region in multiple sclerosis diagnosis: the utility of visual evoked potentials.
    Neurology. 2020 Dec 16. pii: WNL.0000000000011339.
    PubMed     Abstract available


  176. LEVISON LS, Thomsen RW, Sindrup SH, Andersen H, et al
    Association of Hospital-Diagnosed Infections and Antibiotic Use with Risk of Developing Guillain-Barre Syndrome.
    Neurology. 2020 Dec 14. pii: WNL.0000000000011342.
    PubMed     Abstract available


  177. GRAUS F, Dalmau J
    Author response: Hashimoto encephalopathy in the 21st century.
    Neurology. 2020;95:1068.
    PubMed    


  178. SHUBHAKARAN K
    Reader response: Hashimoto encephalopathy in the 21st century.
    Neurology. 2020;95:1067-1068.
    PubMed    


  179. LEE MY, Yong KP, Hyun JW, Kim SH, et al
    Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder.
    Neurology. 2020;95:e3124-e3128.
    PubMed     Abstract available


  180. RUSS JB, Timbie CM, Li Y, Gonzalez-Giraldo E, et al
    Clinical Reasoning: An 11-year-old girl with focal seizures, fevers, and unilateral, enhancing cortical lesions.
    Neurology. 2020;95:e3153-e3159.
    PubMed    


  181. TANBOON J, Inoue M, Hirakawa S, Tachimori H, et al
    Pathological features of anti-Mi-2 dermatomyositis.
    Neurology. 2020 Dec 4. pii: WNL.0000000000011269.
    PubMed     Abstract available


  182. NISHIJIMA H, Suzuki C, Kon T, Nakamura T, et al
    Bilateral Thalamic Lesions Associated with Atezolizumab-induced Autoimmune Encephalitis.
    Neurology. 2020 Dec 2. pii: WNL.0000000000011297.
    PubMed    


  183. NAISMITH RT, Bermel RA, Coffey CS, Goodman AD, et al
    Effects of ibudilast on MRI measures in the phase 2 SPRINT-MS study.
    Neurology. 2020 Dec 2. pii: WNL.0000000000011314.
    PubMed     Abstract available


  184. LANGESKOV-CHRISTENSEN M, Grondahl Hvid L, Nygaard MKE, Ringgaard S, et al
    Efficacy of high-intensity aerobic exercise on brain MRI measures in multiple sclerosis.
    Neurology. 2020 Dec 1. pii: WNL.0000000000011241.
    PubMed     Abstract available


  185. BINZER S, Manouchehrinia A, Hillert J
    Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1026.
    PubMed    


  186. BSTEH G, Berger T
    Reader response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1025-1026.
    PubMed    


  187. GANESH A, Galetta S
    Editors' note: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study.
    Neurology. 2020;95:1025.
    PubMed    


  188. SPATOLA M, Petit Pedrol M, Maudes E, Simabukuro M, et al
    Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis.
    Neurology. 2020;95:e3012-e3025.
    PubMed     Abstract available


    November 2020
  189. MARRIE RA, Maxwell C, Mahar A, Ekuma O, et al
    Cancer incidence and mortality rates in multiple sclerosis: A matched cohort study.
    Neurology. 2020 Nov 25. pii: WNL.0000000000011219.
    PubMed     Abstract available


  190. LI V, Malladi P, Simeoni S, Pakzad M, et al
    A clinico-neurophysiological study of urogenital dysfunction in MOG-antibody transverse myelitis.
    Neurology. 2020;95:e2924-e2934.
    PubMed     Abstract available


  191. MANTEGAZZA R, Wolfe GI, Muppidi S, Wiendl H, et al
    Post-intervention status in patients with refractory myasthenia gravis treated with eculizumab during REGAIN and its open-label extension.
    Neurology. 2020 Nov 23. pii: WNL.0000000000011207.
    PubMed     Abstract available


  192. BRIL V, Benatar M, Andersen H, Vissing J, et al
    Efficacy and safety of rozanolixizumab in moderate-to-severe generalised myasthenia gravis: A phase 2 RCT.
    Neurology. 2020 Nov 20. pii: WNL.0000000000011108.
    PubMed     Abstract available


  193. FEIBEL RM
    Henry R. Viets, MD, and the history of myasthenia gravis.
    Neurology. 2020 Nov 20. pii: WNL.0000000000011239.
    PubMed     Abstract available


  194. NARAYANASWAMI P, Sanders DB, Wolfe G, Benatar M, et al
    International consensus guidance for management of myasthenia gravis: 2020 update.
    Neurology. 2020 Nov 3. pii: WNL.0000000000011124.
    PubMed     Abstract available


  195. HOANG P, Hurtubise B, Muppidi S
    Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.
    Neurology. 2020;95:840-843.
    PubMed    


    October 2020
  196. KOCH MW, Mostert J, Repovic P, Bowen JD, et al
    Reliability of outcome measures in clinical trials in secondary progressive multiple sclerosis.
    Neurology. 2020 Oct 26. pii: WNL.0000000000011123.
    PubMed     Abstract available


  197. KLEIN DA COSTA B, Brant de Souza Melo R, Passos GRD, Gomes Meneses Sevilha Castro D, et al
    Unraveling B lymphocytes in CNS inflammatory diseases: Distinct mechanisms and treatment targets.
    Neurology. 2020;95:733-744.
    PubMed     Abstract available


  198. MASTRANGELO V, Asioli GM, Foschi M, Padroni M, et al
    Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease.
    Neurology. 2020;95:648-649.
    PubMed    


  199. FELIPE-RUCIAN A, Wegener-Panzer A, Nassenstein I, Reindl M, et al
    Teaching NeuroImages: Bilateral optic neuritis: When to suspect anti-MOG antibodies.
    Neurology. 2020;95:e2045-e2046.
    PubMed    


    September 2020
  200. RINGELSTEIN M, Harmel J, Zimmermann H, Brandt AU, et al
    Author response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
    Neurology. 2020;95:610.
    PubMed    


  201. CHEN JJ
    Reader response: Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
    Neurology. 2020;95:609-610.
    PubMed    


  202. GIANNOCCARO MP, Paolucci M, Zenesini C, Di Stasi V, et al
    Comparison of ice pack test and single-fiber EMG diagnostic accuracy in patients referred for myasthenic ptosis.
    Neurology. 2020;95:e1800-e1806.
    PubMed     Abstract available



  203. Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.
    Neurology. 2020 Sep 16. pii: WNL.0000000000008927.
    PubMed    


  204. MOCCIA M, van de Pavert S, Eshaghi A, Haider L, et al
    Pathological correlates of the magnetization transfer ratio in multiple sclerosis.
    Neurology. 2020 Sep 16. pii: WNL.0000000000010909.
    PubMed     Abstract available


  205. SHELLY S, Paul P, Bi H, Dubey D, et al
    Improving accuracy of myasthenia gravis autoantibody testing by reflex algorithm.
    Neurology. 2020 Sep 16. pii: WNL.0000000000010910.
    PubMed     Abstract available


  206. ROTSTEIN DL, Yeh EA
    Could wider social networks prevent disability in MS and other neurologic disorders?
    Neurology. 2020;95:463-464.
    PubMed    


  207. LIBERATORE G, De Santis T, Doneddu PE, Gentile F, et al
    Clinical Reasoning: A case of COVID-19 associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome.
    Neurology. 2020 Sep 11. pii: WNL.0000000000010817.
    PubMed    


  208. KULICK-SOPER CV, McKee JL, Wolf RL, Mohan S, et al
    Pearls & Oy-sters: Bilateral globus pallidus lesions in a patient with COVID-19.
    Neurology. 2020;95:454-457.
    PubMed    


  209. VIRHAMMAR J, Kumlien E, Fallmar D, Frithiof R, et al
    Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.
    Neurology. 2020;95:445-449.
    PubMed     Abstract available


  210. BENITO-LEON J, Mendez-Guerrero A, Gutierrez-Ortiz C
    Author response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:409.
    PubMed    


  211. NI J, Xu X
    Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:408-409.
    PubMed    


  212. SIEGLER JE 3RD, Galetta S
    Editors' note: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:408.
    PubMed    


  213. SEESE RR, Guillen D, Gaesser JM, Abdel-Hamid HZ, et al
    Clinical Reasoning: A 14-year-old boy with acute weakness, paresthesias, and headache.
    Neurology. 2020;95:e1285-e1289.
    PubMed    


  214. KWON YN, Jung JH, Kim SJ, Sung JJ, et al
    Progressive brain atrophy and white matter changes in MOG encephalomyelitis.
    Neurology. 2020;95:402-403.
    PubMed    


    August 2020
  215. BENITO-LEON J, Mendez-Guerrero A, Gutierrez-Ortiz C
    Author response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:370.
    PubMed    


  216. VAVOUGIOS GD
    Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:369.
    PubMed    


  217. VAIRA LA, Salzano G, De Riu G
    Reader response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:368-369.
    PubMed    


  218. LEWIS A, Galetta S
    Editors' note: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:368.
    PubMed    


  219. WALLIN MT
    Initial highly effective therapy for MS: A strong start.
    Neurology. 2020;95:e1114-e1116.
    PubMed    


  220. SECHI E, Markovic SN, McKeon A, Dubey D, et al
    Neurological autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes.
    Neurology. 2020 Aug 13. pii: WNL.0000000000010632.
    PubMed     Abstract available


  221. DOUGHTY CT, Guidon AC
    Stronger together: Diagnostic testing for ocular myasthenia gravis.
    Neurology. 2020 Aug 11. pii: WNL.0000000000010616.
    PubMed    


  222. RUPRECHT K, Pfuhl C, Oechtering J
    Author response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Neurology. 2020;95:277-278.
    PubMed    


  223. ALCALA C, Perez-Miralles FC, Gil-Perotin S, Casanova B, et al
    Reader response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Neurology. 2020;95:277.
    PubMed    


  224. SIEGLER JE 3RD, Galetta S
    Editors' note: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
    Neurology. 2020;95:276.
    PubMed    


  225. OUTTERYCK O, Lopes R, Drumez E, Labreuche J, et al
    Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome.
    Neurology. 2020;95:e733-e744.
    PubMed     Abstract available


  226. VAN KEMPEN ZLE, Hoogervorst ELJ, Wattjes MP, Kalkers NF, et al
    Personalized extended interval dosing of natalizumab in MS: A prospective multicenter trial.
    Neurology. 2020;95:e745-e754.
    PubMed     Abstract available


  227. DIXON L, Shah S
    Teaching NeuroImages: Hypertrophic polyneuropathy.
    Neurology. 2020;95:e779-e780.
    PubMed    


  228. LEE I, Kuo HC, Aban IB, Cutter GR, et al
    Minimal manifestation status and prednisone withdrawal in the MGTX trial.
    Neurology. 2020;95:e755-e766.
    PubMed     Abstract available


  229. ARINO H, Munoz-Lopetegi A, Martinez-Hernandez E, Armangue T, et al
    Sleep disorders in anti-NMDAR encephalitis.
    Neurology. 2020;95:e671-e684.
    PubMed     Abstract available


  230. LEVIN SN, Riley CS, Dhand A, White CC, et al
    Association of Social Network Structure and Physical Function in Patients With Multiple Sclerosis.
    Neurology. 2020 Aug 7. pii: WNL.0000000000010460.
    PubMed     Abstract available


  231. MENDOZA M, Tran C, Bril V, Katzberg HD, et al
    Patient-acceptable symptom states in myasthenia gravis.
    Neurology. 2020 Aug 5. pii: WNL.0000000000010574.
    PubMed     Abstract available


  232. PIEHL F, Wolfe GI
    Is the treatment of myasthenia gravis improving? Why not ask our patients?
    Neurology. 2020 Aug 5. pii: WNL.0000000000010578.
    PubMed    


  233. DINKIN M, Gao V, Kahan J, Bobker S, et al
    COVID-19 presenting with ophthalmoparesis from cranial nerve palsy.
    Neurology. 2020;95:221-223.
    PubMed    


  234. GUTIERREZ-ORTIZ C, Mendez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, et al
    Miller Fisher syndrome and polyneuritis cranialis in COVID-19.
    Neurology. 2020;95:e601-e605.
    PubMed     Abstract available


  235. NELSON LM, Bourdette D
    Two decades of research: Time to incorporate comorbidity management into the care of MS?
    Neurology. 2020;95:193-194.
    PubMed    


  236. SALTER A, Kowalec K, Fitzgerald KC, Cutter G, et al
    Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial.
    Neurology. 2020;95:e446-e456.
    PubMed     Abstract available


  237. BOSE G, Fitzpatrick T, Yogendrakumar V, Zwicker JC, et al
    Clinical Reasoning: A 73-year-old man with recurrent aphasia, headaches and confusion.
    Neurology. 2020 Aug 4. pii: WNL.0000000000010475.
    PubMed    


    July 2020
  238. KILLESTEIN J, Du Pasquier R, Hemmer B
    Vaccination in B-cell depleted MS patients.
    Neurology. 2020 Jul 29. pii: WNL.0000000000010378.
    PubMed    


  239. BAR-OR A, Calkwood JC, Chognot C, Evershed J, et al
    Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
    Neurology. 2020 Jul 29. pii: WNL.0000000000010380.
    PubMed     Abstract available


  240. VILLOSLADA P, Sanchez-Dalmau B, Galetta S
    Optical coherence tomography: A useful tool for identifying subclinical optic neuropathy in diagnosing multiple sclerosis.
    Neurology. 2020 Jul 28. pii: WNL.0000000000009840.
    PubMed    


  241. HAUSER SL, Kappos L, Arnold DL, Bar-Or A, et al
    Five-years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
    Neurology. 2020 Jul 20. pii: WNL.0000000000010376.
    PubMed     Abstract available


  242. SANTORO JD, Waltz M, Aaen G, Belman A, et al
    Pediatric Multiple Sclerosis Severity Score in a Large U.S. Cohort.
    Neurology. 2020 Jul 20. pii: WNL.0000000000010414.
    PubMed     Abstract available


  243. KAPOOR R, Smith KE, Allegretta M, Arnold DL, et al
    Serum neurofilament light as a biomarker in progressive multiple sclerosis.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010346.
    PubMed     Abstract available


  244. HERRAETS IJT, Goedee HS, Telleman JA, van Eijk RPA, et al
    Nerve ultrasound for diagnosing chronic inflammatory neuropathy: a multicenter validation study.
    Neurology. 2020 Jul 16. pii: WNL.0000000000010369.
    PubMed     Abstract available


  245. HERMAN C, Mayer K, Sarwal A
    Scoping review of prevalence of neurologic comorbidities in patients hospitalized for COVID-19.
    Neurology. 2020;95:77-84.
    PubMed     Abstract available


  246. CHEN JJ, Flanagan EP, Bhatti MT, Jitprapaikulsan J, et al
    Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder.
    Neurology. 2020;95:e111-e120.
    PubMed     Abstract available


  247. MANISCALCO GT, Mariotto S, Hoftberger R, Capra R, et al
    GABAA receptor autoimmunity after alemtuzumab treatment for multiple sclerosis.
    Neurology. 2020 Jul 10. pii: WNL.0000000000010310.
    PubMed    


  248. GIOVANNONI G, Knappertz V, Steinerman JR, Tansy AP, et al
    A randomized, placebo-controlled phase 2 trial of laquinimod in primary progressive multiple sclerosis.
    Neurology. 2020 Jul 10. pii: WNL.0000000000010284.
    PubMed     Abstract available


  249. FERREIRA D, Ferro D, Bastos G, Pinto M, et al
    Teaching NeuroImages: Useless (and restless) hand of Oppenheim in multiple sclerosis.
    Neurology. 2020 Jul 9. pii: WNL.0000000000010261.
    PubMed    


  250. TOMSCHIK M, Hilger E, Rath J, Mayer EM, et al
    Subgroup Stratification and Outcome in Recently Diagnosed Generalized Myasthenia Gravis.
    Neurology. 2020 Jul 8. pii: WNL.0000000000010209.
    PubMed     Abstract available


  251. BURON MD, Chalmer TA, Sellebjerg F, Barzinji I, et al
    Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
    Neurology. 2020 Jul 7. pii: WNL.0000000000010135.
    PubMed     Abstract available


    June 2020
  252. PONCIANO A, Carvalho JN, Gala D, Leite J, et al
    Pearls & Oy-sters: Guillain-Barre syndrome: An unusual presentation of acute intermittent porphyria.
    Neurology. 2020 Jun 19. pii: WNL.0000000000009838.
    PubMed    


  253. RUITER AM, Naber WC, Tannemaat MR, Verschuuren JJGM, et al
    The face of myasthenia gravis.
    Neurology. 2020 Jun 10. pii: WNL.0000000000009782.
    PubMed    


  254. JONSSON DI, Sveinsson O, Hakim R, Brundin L, et al
    Author response: Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.
    Neurology. 2020;94:1049-1050.
    PubMed    


  255. PAPP V, Petersen T, Magyari M, Koch-Henriksen N, et al
    Reader response: Epidemiology of NMOSD in Sweden from 1987 to 2013: A nationwide population-based study.
    Neurology. 2020;94:1048-1049.
    PubMed    


  256. VAN KEMPEN ZLE, Kryscio RJ, Dalla Costa G
    Serum neurofilament light as a prognostic marker for MS disability: Are we there yet?
    Neurology. 2020;94:1013-1014.
    PubMed    


  257. DAVION JB, Lopes R, Drumez E, Labreuche J, et al
    Asymptomatic optic nerve lesions: An underestimated cause of silent retinal atrophy in MS.
    Neurology. 2020;94:e2468-e2478.
    PubMed     Abstract available


  258. BIRCA V, Saint-Martin C, Myers KA
    Teaching Video NeuroImages: Pathologic yawning: A sign of brainstem involvement in acute disseminated encephalomyelitis?
    Neurology. 2020;94:e2497-e2498.
    PubMed    


  259. COSTELLO F, Dalakas MC
    Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.
    Neurology. 2020 Jun 2. pii: WNL.0000000000009921.
    PubMed     Abstract available


  260. ALLENBACH Y, Uzunhan Y, Toquet S, Leroux G, et al
    Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.
    Neurology. 2020 Jun 2. pii: WNL.0000000000009727.
    PubMed     Abstract available


  261. GUIDON AC, Amato AA
    COVID-19 and neuromuscular disorders.
    Neurology. 2020;94:959-969.
    PubMed     Abstract available


  262. MARRIE RA, Leavitt VM
    Disease-modifying therapies as cognition-modifying therapies? Treating cognitive impairment in MS.
    Neurology. 2020;94:957-958.
    PubMed    


  263. MARTINEZ-HERNANDEZ E, Guasp M, Garcia-Serra A, Maudes E, et al
    Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies.
    Neurology. 2020;94:e2302-e2310.
    PubMed     Abstract available


  264. CORREALE J, Marrodan M, Benarroch EE
    What is the role of axonal ion channels in multiple sclerosis?
    Neurology. 2020 Jun 1. pii: WNL.0000000000009754.
    PubMed    


    May 2020
  265. LUBLIN FD, Coetzee T, Cohen JA, Marrie RA, et al
    The 2013 clinical course descriptors for multiple sclerosis: A clarification.
    Neurology. 2020 May 29. pii: WNL.0000000000009636.
    PubMed     Abstract available


  266. RAFAY MF, Shapiro KA, Surmava AM, deVeber GA, et al
    Spectrum of cerebral arteriopathies in children with arterial ischemic stroke.
    Neurology. 2020 May 26. pii: WNL.0000000000009557.
    PubMed     Abstract available


  267. MANOUCHEHRINIA A, Stridh P, Khademi M, Leppert D, et al
    Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis.
    Neurology. 2020 May 20. pii: WNL.0000000000009571.
    PubMed     Abstract available


  268. LANDMEYER NC, Burkner PC, Wiendl H, Ruck T, et al
    Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis.
    Neurology. 2020 May 19. pii: WNL.0000000000009522.
    PubMed     Abstract available


  269. LAMBE J, Rothman A, Prince J, Saidha S, et al
    Retinal pathology occurs in stiff-person syndrome.
    Neurology. 2020;94:e2126-e2131.
    PubMed     Abstract available


  270. DALE RC, Rostasy K
    Autoimmune pediatric neuropsychiatric symptoms with pain and hypertension: CASPR2 antibody.
    Neurology. 2020 May 18. pii: WNL.0000000000009521.
    PubMed    


  271. SYRBE S, Stettner GM, Bally J, Borggraefe I, et al
    CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension.
    Neurology. 2020 May 18. pii: WNL.0000000000009523.
    PubMed     Abstract available


  272. MATHIS S, Soulages A, Le Masson G, Vallat JM, et al
    History of acute polyradiculoneuropathy (part 2): From 1916 to 2019.
    Neurology. 2020;94:836-840.
    PubMed     Abstract available


  273. VAN OMMEREN R, Izenberg A, Shadowitz S, Aviv R, et al
    Clinical Reasoning: An 81-year-old woman with decreased consciousness and fluctuating right facial droop.
    Neurology. 2020;94:843-848.
    PubMed    


  274. CORTESE M, Munger KL, Martinez-Lapiscina EH, Barro C, et al
    Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.
    Neurology. 2020;94:e1950-e1960.
    PubMed     Abstract available


  275. GADOT R, Nascimento FA, Mims M, Nunez-Wallace K, et al
    Clinical Reasoning: A 59-year-old woman with multiple myeloma and lower extremity weakness and numbness.
    Neurology. 2020;94:794-800.
    PubMed    


    April 2020
  276. ARUN T, Pattison L, Palace J
    Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective cohort study.
    Neurology. 2020 Apr 30. pii: WNL.0000000000009491.
    PubMed     Abstract available


  277. MATHIS S, Soulages A, Vallat JM, Le Masson G, et al
    History of acute polyradiculoneuropathy (part 1): The prehistory of Guillain-Barre syndrome.
    Neurology. 2020 Apr 28. pii: WNL.0000000000009401.
    PubMed     Abstract available


  278. KIM HW, Lamb C, Jamali S, Lopez Chiriboga AS, et al
    Mystery Case: Anti-NMDAR encephalitis with overlapping demyelinating syndrome.
    Neurology. 2020;94:e1866-e1869.
    PubMed    


  279. NISHI R, Koike H, Ohyama K, Fukami Y, et al
    Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA.
    Neurology. 2020;94:e1726-e1737.
    PubMed     Abstract available


  280. POUPART J, Giovannelli J, Deschamps R, Audoin B, et al
    Evaluation of efficacy and tolerability of first-line therapies in NMOSD.
    Neurology. 2020;94:e1645-e1656.
    PubMed     Abstract available


  281. HUSSEIN O, Jordan Z, Abd Elazim A, Stino A, et al
    Pearls & Oy-sters: Rapid progression of prion disease associated with transverse myelitis: A rare presentation.
    Neurology. 2020;94:e1670-e1672.
    PubMed    


  282. LANGER-GOULD A, Smith JB, Albers KB, Xiang AH, et al
    Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohort.
    Neurology. 2020 Apr 13. pii: WNL.0000000000009374.
    PubMed     Abstract available


  283. DOBSON R, Mowry EM
    Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis.
    Neurology. 2020 Apr 13. pii: WNL.0000000000009369.
    PubMed    


  284. MEALY MA, Kozachik SL, Cook LJ, Totonis L, et al
    Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial.
    Neurology. 2020 Apr 8. pii: WNL.0000000000009370.
    PubMed     Abstract available


  285. LEAVITT VM
    Neurologic determinism? Key update to an age-old debate.
    Neurology. 2020;94:605-606.
    PubMed    


  286. BROWNLEE W, Bourdette D, Broadley S, Killestein J, et al
    Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.
    Neurology. 2020 Apr 2. pii: WNL.0000000000009507.
    PubMed     Abstract available


    March 2020
  287. CARVALHO NETO EG, Gomes MF, Dos Santos IP, Monteiro MD, et al
    Teaching Video NeuroImages: Useful bedside testing for myasthenia gravis: The phenomenon of enhanced ptosis.
    Neurology. 2020 Mar 31. pii: WNL.0000000000009238.
    PubMed    


  288. DE MEEL RHP, Keene KR, Wirth MA, Weber KP, et al
    Repetitive ocular vestibular evoked myogenic potentials in myasthenia gravis.
    Neurology. 2020 Mar 26. pii: WNL.0000000000009306.
    PubMed     Abstract available


  289. GRONSETH GS, Barohn R, Narayanaswami P
    Practice advisory: Thymectomy for myasthenia gravis (practice parameter update): Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Neurology. 2020 Mar 25. pii: WNL.0000000000009294.
    PubMed     Abstract available


  290. ARGYROPOULOS GPD, Moore L, Loane C, Roca-Fernandez A, et al
    Pathologic tearfulness after limbic encephalitis: A novel disorder and its neural basis.
    Neurology. 2020;94:e1320-e1335.
    PubMed     Abstract available


  291. YEH EA, Sormani MP
    Tracking therapies in MS: More evidence in favor of neurofilament.
    Neurology. 2020;94:465-466.
    PubMed    


  292. RICE J, Woltjer R, Stienstra N, Sun E, et al
    Pearls & Oy-sters: Primary angiitis of the CNS presenting with recurrent intracranial hemorrhage.
    Neurology. 2020;94:e992-e995.
    PubMed    


    February 2020
  293. MACARON G, Willis MA, Ontaneda D, Fernandez H, et al
    Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorder.
    Neurology. 2020;94:273-275.
    PubMed    


  294. KAPOOR M, Spillane J, Englezou C, Sarri-Gonzalez S, et al
    Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy.
    Neurology. 2020;94:e635-e638.
    PubMed     Abstract available


  295. LIPKA AF, Boldingh MI, van Zwet EW, Schreurs MWJ, et al
    Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome.
    Neurology. 2020;94:e511-e520.
    PubMed     Abstract available


    January 2020
  296. HERRAETS IJT, Goedee HS, Telleman JA, van Eijk RPA, et al
    Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies.
    Neurology. 2020 Jan 20. pii: WNL.0000000000008978.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: